Flex Pharma Appoints Kathie Lindemann Chief Operating Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Flex Pharma (FLKS) Appoints New COO
September 9, 2015 10:18 AM EDTFlex Pharma (NASDAQ: FLKS) announced the appointment of Kathie Lindemann as its Chief Operating Officer, reporting to Christoph Westphal M.D., Ph.D., Flex Pharmas President, CEO and Chair.
Prior to joining Flex Pharma, Ms. Lindemann served as Chief Operating Officer at DAVIDs TEA Inc (NYSE: DTEA). Ms.... More
